We are a national, non-profit organization dedicated to
People in Canada
Living with Psoriasis & Psoriatic Arthritis
Our goal is to improve the lives of people living with psoriasis and psoriatic arthritis by providing current information on research and treatment options.
WEBINAR: Living well with psoriatic disease
Join us October 12 at 7:30 ET to discuss Living Well With Psoriatic Disease.
Deucravacitinib Common Drug Review Patient Input Submission Survey
Do you have psoriasis? Do you care for someone who does? We need your valuable input!
The Canadian Psoriasis Network (CPN) and the Canadian Association of Psoriasis Patients (CAPP) are working together to tell decision makers more about psoriasis and experiences with deucravacitinib for the treatment of moderate to severe plaque psoriasis.
Interactive Drug Coverage Finder
Did you know: The Canadian Skin Patient Alliance (CSPA) developed an interactive drug coverage finder!
Current State of the COVID-19 Pandemic for the Psoriasis and Psoriatic Arthritis Community
Dr. Mark Kirchhof, MD, PhD, FRCPC, Head of the Division of Dermatology, Faculty of Medicine, University of Ottawa and The Ottawa Hospital, provides an overview of the current state of knowledge about psoriasis and COVID-19. Research is constantly evolving and the information presented in this webinar reflects the date of its original publication (May 2, 2022).
IMD Health Global
CPN is pleased to be partnered with IMD Health Global (IMD). IMD is focused on health education, providing engaging and informative resources to healthcare providers, patients, and their families via the IMD Health Patient Engagement Platform.
INVISIBLE MAN : a Real Life Psoriasis Story
Invisible Man tells the inspiring story of CPN’s founder, Andrew Gosse’s journey to treatment after suffering from severe psoriasis for 18 years. Directed by award winning filmmaker Nimisha Mukerji. Executive Producer C. Hudson Hwang.
Thank you to all of our individual donors and to our corporate funders!
We couldn't do it without you.
Do you have any questions or suggestions for us? We would love to hear from you.